Is Aspira Pathlab & Diagnostics Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Aspira Pathlab & Diagnostics Ltd (540788.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Aspira Pathlab & Diagnostics Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Aspira Pathlab & Diagnostics Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Aspira Pathlab & Diagnostics Ltd?

Muslim investors may consider investing in Aspira Pathlab & Diagnostics Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Aspira Pathlab & Diagnostics Ltd classified as HALAL?

Musaffa determines the Shariah status of Aspira Pathlab & Diagnostics Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Aspira Pathlab & Diagnostics Ltd updated?

The Shariah compliance status of Aspira Pathlab & Diagnostics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Aspira Pathlab & Diagnostics Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Aspira Pathlab & Diagnostics Ltd?

You can check the latest Shariah compliance status of Aspira Pathlab & Diagnostics Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Aspira Pathlab & Diagnostics Ltd 540788.BO

₹90.99 ₹5.11 (5.95%) 1D

Last Updated: May 15, 12:00 AM·BSE

540788.BO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 28, 2026

Report Source: 2026 2nd Quarter Report

Aspira Pathlab & Diagnostics Ltd. Stock Analysis 540788.BO

India N/A Nano Cap Report: Q2, 2026

Aspira Pathlab & Diagnostics Ltd. engages in the operation of diagnostic centers and laboratories. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2017-12-05. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The firm carries out pathological investigations in various branches, including biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The firm's tests include pathology test, sonography, x-ray, and radiology. Its pathology tests include Influenza (Flu) Panel with H3N2, Blood chromosome analysis, Filmarray multiplex PCR(BIOFIRE) Pneumonia Panel Plus, Polycystic Ovarian Syndrome (PCOS) 2, Typhoid PCR, Dengue-Chikungunya-Malaria multiplex PCR, Vitamin And TSH, Fever screening profile-2, and others.

Key Statistics of Aspira Pathlab & Diagnostics Ltd (540788.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹85.88₹90.99

Today's Open

₹85.88

Volume

4694.00

P/E Ratio (TTM)

38.92

52 Week Range

₹49.00₹90.99

Market Cap

586.57M

Avg. Volume

6409.91

Dividend Yield

Financial Metrics & Statements of Aspira Pathlab & Diagnostics Ltd (540788.BO)

FAQ's for Aspira Pathlab & Diagnostics Ltd (540788.BO)

According to Musaffa’s Shariah screening methodology, Aspira Pathlab & Diagnostics Ltd (540788.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.